GRL-0617，98%，一种强效, 选择性和竞争性的 SARS-CoV Plpro/deubiquitinase 的非共价抑制剂, IC50 值为 0.6 Μm, Ki 值为 0.49 μM

GRL-0617, 98%, a potent, selective and competitive noncovalent inhibitor of severe acute respiratory syndrome (SARS-CoV) papain-like protease (PLpro)/deubiquitinase, with an IC50 of 0.6 μM, and with a Ki of 0.49 μM

仅供研发或工业应用，不可直接用于食品、药品、临床诊断或治疗。